form_ex23-835.htm

0000312555-12-000010.txt : 20121228 0000312555-12-000010.hdr.sgml : 20121228 20121228114532 ACCESSION NUMBER: 0000312555-12-000010 CONFORMED SUBMISSION TYPE: NSAR-B PUBLIC DOCUMENT COUNT: 5 CONFORMED PERIOD OF REPORT: 20121031 FILED AS OF DATE: 20121228 DATE AS OF CHANGE: 20121228 EFFECTIVENESS DATE: 20121228 FILER: COMPANY DATA: COMPANY CONFORMED NAME: OPPENHEIMER EQUITY INCOME FUND INC CENTRAL INDEX KEY: 0000799029 IRS NUMBER: 132527171 STATE OF INCORPORATION: MD FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: NSAR-B SEC ACT: 1940 Act SEC FILE NUMBER: 811-04797 FILM NUMBER: 121289484 BUSINESS ADDRESS: STREET 1: 6803 SOUTH TUCSON WAY STREET 2: N/A CITY: CENTENNIAL STATE: CO ZIP: 80112-3924 BUSINESS PHONE: 303-768-3200 MAIL ADDRESS: STREET 1: 6803 SOUTH TUCSON WAY STREET 2: N/A CITY: CENTENNIAL STATE: CO ZIP: 80112-3924 FORMER COMPANY: FORMER CONFORMED NAME: OPPENHEIMER QUEST CAPITAL VALUE FUND INC DATE OF NAME CHANGE: 19970303 FORMER COMPANY: FORMER CONFORMED NAME: QUEST FOR VALUE DUAL PURPOSE FUND INC DATE OF NAME CHANGE: 19920703 FORMER COMPANY: FORMER CONFORMED NAME: QFV DUAL PURPOSE FUND INC DATE OF NAME CHANGE: 19870111

0000799029 S000008498 OPPENHEIMER EQUITY INCOME FUND, INC.

C000023330 A

C000023331 B

C000031353 C

C000031354 N

C000098424 Y

C000110903 I

NSAR-B 1 answer.fil OPPENHEIMER EQUITY INCOME FUND, INC. PAGE 1 000 B000000 10/31/2012 000 C000000 799029 000 D000000 N 000 E000000 NF 000 F000000 Y 000 G000000 N 000 H000000 N 000 I000000 6.1 000 J000000 A 001 A000000 OPPENHEIMER EQUITY INCOME FUND, INC. 001 B000000 811-04797 001 C000000 3037683468 002 A000000 6803 S. Tucson Way 002 B000000 Centennial 002 C000000 CO 002 D010000 80112 002 D020000 3924 003 000000 N 004 000000 N 005 000000 N 006 000000 N 007 A000000 N 007 B000000 0 007 C010100 1 008 A000001 OPPENHEIMERFUNDS, INC. 008 B000001 A 008 C000001 801-8253 008 D010001 NEW YORK 008 D020001 NY 008 D030001 10281 008 D040001 1008 011 A000001 OPPENHEIMERFUNDS DISTRIBUTOR, INC. 011 B000001 8-22992 011 C010001 NEW YORK 011 C020001 NY 011 C030001 10281 011 C040001 1008 012 A000001 OPPENHEIMERFUNDS, INC. 012 B000001 84-01562 012 C010001 CENTENNIAL 012 C020001 CO 012 C030001 80112 012 C040001 3924 013 A000001 KPMG LLP 013 B010001 DENVER 013 B020001 CO 013 B030001 80202 015 A000001 BROWN BROTHERS HARRIMAN & CO. 015 B000001 C 015 C010001 BOSTON 015 C020001 MA PAGE 2 015 C030001 02109 015 C040001 3661 015 E010001 X 018 000000 Y 019 A000000 Y 019 B000000 84 019 C000000 OPPENHEIMR 020 A000001 BGC FINANCIAL, L.P. 020 B000001 30-0563735 020 C000001 1337 020 A000002 BARCLAYS CAPITAL, INC. 020 B000002 06-1031656 020 C000002 1052 020 A000003 MORGAN STANLEY & CO. LLC 020 B000003 13-2655998 020 C000003 636 020 A000004 UBS SECURITIES LLC 020 B000004 98-0186363 020 C000004 468 020 A000005 OTR GLOBAL TRADING LLC 020 B000005 13-3247006 020 C000005 443 020 A000006 GOLDMAN, SACHS & CO. 020 B000006 13-5108880 020 C000006 339 020 A000007 WEEDEN & CO L.P. 020 B000007 13-3287114 020 C000007 130 020 A000008 MERRILL LYNCH, PIERCE, FENNER & SMITH INC. 020 B000008 13-5674085 020 C000008 102 020 A000009 J.P. MORGAN SECURITIES LLC 020 B000009 13-3224016 020 C000009 93 020 A000010 CANTOR FITZGERALD & CO. 020 B000010 95-1786286 020 C000010 63 021 000000 5131 022 A000001 CREDIT SUISSE SECURITIES (USA) LLC 022 B000001 13-8988118 022 C000001 739 022 D000001 10524 022 A000002 GOLDMAN, SACHS & CO. 022 B000002 13-5108880 022 C000002 9433 022 D000002 0 022 A000003 J.P. MORGAN SECURITIES LLC 022 B000003 13-3224016 022 C000003 3441 022 D000003 5029 022 A000004 BARCLAYS CAPITAL, INC. PAGE 3 022 B000004 06-1031656 022 C000004 5535 022 D000004 808 022 A000005 CITIGROUP GLOBAL MARKETS INC. 022 B000005 11-2418191 022 C000005 4976 022 D000005 1321 022 A000006 JEFFERIES & COMPANY, INC. 022 B000006 95-2622900 022 C000006 3744 022 D000006 352 022 A000007 DEUTSCHE BANK SECURITIES INC. 022 B000007 13-2730828 022 C000007 956 022 D000007 2411 022 A000008 GMP SECURITIES, LLC 022 C000008 3104 022 D000008 0 022 A000009 MERRILL LYNCH, PIERCE, FENNER & SMITH INC. 022 B000009 13-5674085 022 C000009 1857 022 D000009 669 022 A000010 RBC CAPITAL MARKETS, LLC 022 B000010 41-1416330 022 C000010 1897 022 D000010 32 023 C000000 43173 023 D000000 24741 024 000000 Y 025 A000001 JP Morgan Chase 025 B000001 13-3224016 025 C000001 E 025 D000001 132066 025 A000002 WELLS FARGO 025 B000002 94-3379992 025 C000002 E 025 D000002 72513 025 A000003 BANK OF AMERICA 025 B000003 56-2058405 025 C000003 D 025 D000003 243 025 A000004 CIT Group 025 B000004 13-8988118 025 C000004 E 025 D000004 20018 025 A000005 CITIGROUP 025 B000005 11-2418191 025 C000005 E 025 D000005 18814 025 A000006 CITIGROUP 025 B000006 11-2418191 PAGE 4 025 C000006 D 025 D000006 1141 025 A000007 MERRILL LYNCH 025 B000007 13-5674085 025 C000007 D 025 D000007 465 026 A000000 N 026 B000000 Y 026 C000000 N 026 D000000 Y 026 E000000 N 026 F000000 N 026 G010000 N 026 G020000 N 026 H000000 N 027 000000 Y 028 A010000 73851 028 A020000 0 028 A030000 0 028 A040000 65060 028 B010000 67998 028 B020000 17816 028 B030000 0 028 B040000 57306 028 C010000 64980 028 C020000 0 028 C030000 0 028 C040000 52853 028 D010000 69799 028 D020000 0 028 D030000 0 028 D040000 59891 028 E010000 77600 028 E020000 15307 028 E030000 0 028 E040000 62842 028 F010000 125821 028 F020000 0 028 F030000 0 028 F040000 75984 028 G010000 480049 028 G020000 33123 028 G030000 0 028 G040000 373936 028 H000000 211545 029 000000 Y 030 A000000 5495 030 B000000 5.75 030 C000000 0.00 031 A000000 1298 031 B000000 0 PAGE 5 032 000000 4197 033 000000 0 034 000000 Y 035 000000 405 036 A000000 N 036 B000000 0 037 000000 N 038 000000 0 039 000000 N 040 000000 Y 041 000000 Y 042 A000000 0 042 B000000 0 042 C000000 0 042 D000000 0 042 E000000 0 042 F000000 0 042 G000000 0 042 H000000 0 043 000000 11346 044 000000 11435 045 000000 Y 046 000000 N 047 000000 Y 048 000000 0.000 048 A010000 400000 048 A020000 0.700 048 B010000 400000 048 B020000 0.680 048 C010000 400000 048 C020000 0.650 048 D010000 400000 048 D020000 0.600 048 E010000 400000 048 E020000 0.550 048 F010000 3000000 048 F020000 0.500 048 G010000 0 048 G020000 0.000 048 H010000 0 048 H020000 0.000 048 I010000 0 048 I020000 0.000 048 J010000 0 048 J020000 0.000 048 K010000 5000000 048 K020000 0.450 049 000000 N 050 000000 N 051 000000 N 052 000000 N PAGE 6 053 A000000 Y 053 B000000 Y 053 C000000 N 054 A000000 Y 054 B000000 Y 054 C000000 Y 054 D000000 N 054 E000000 N 054 F000000 N 054 G000000 Y 054 H000000 Y 054 I000000 N 054 J000000 Y 054 K000000 N 054 L000000 Y 054 M000000 Y 054 N000000 N 054 O000000 Y 055 A000000 N 055 B000000 N 056 000000 Y 057 000000 N 058 A000000 N 059 000000 Y 060 A000000 Y 060 B000000 Y 061 000000 1000 062 A000000 N 062 B000000 0.0 062 C000000 0.0 062 D000000 0.0 062 E000000 0.0 062 F000000 0.0 062 G000000 0.0 062 H000000 0.0 062 I000000 0.0 062 J000000 0.0 062 K000000 0.0 062 L000000 0.0 062 M000000 0.0 062 N000000 0.0 062 O000000 0.0 062 P000000 0.0 062 Q000000 0.0 062 R000000 0.0 063 A000000 0 063 B000000 0.0 066 A000000 Y 066 B000000 N 066 C000000 N 066 D000000 N PAGE 7 066 E000000 N 066 F000000 N 066 G000000 Y 067 000000 N 068 A000000 N 068 B000000 N 069 000000 N 070 A010000 Y 070 A020000 N 070 B010000 Y 070 B020000 Y 070 C010000 Y 070 C020000 N 070 D010000 Y 070 D020000 N 070 E010000 N 070 E020000 N 070 F010000 Y 070 F020000 N 070 G010000 Y 070 G020000 N 070 H010000 Y 070 H020000 N 070 I010000 Y 070 I020000 N 070 J010000 Y 070 J020000 Y 070 K010000 Y 070 K020000 Y 070 L010000 Y 070 L020000 Y 070 M010000 Y 070 M020000 Y 070 N010000 Y 070 N020000 N 070 O010000 Y 070 O020000 N 070 P010000 Y 070 P020000 Y 070 Q010000 N 070 Q020000 N 070 R010000 Y 070 R020000 Y 071 A000000 966412 071 B000000 875511 071 C000000 2953714 071 D000000 30 072 A000000 12 072 B000000 17569 072 C000000 91926 072 D000000 0 PAGE 8 072 E000000 40 072 F000000 18055 072 G000000 2 072 H000000 0 072 I000000 6265 072 J000000 35 072 K000000 0 072 L000000 0 072 M000000 59 072 N000000 290 072 O000000 0 072 P000000 0 072 Q000000 0 072 R000000 13 072 S000000 49 072 T000000 11488 072 U000000 0 072 V000000 0 072 W000000 966 072 X000000 37222 072 Y000000 17 072 Z000000 72330 072AA000000 93447 072BB000000 0 072CC010000 280764 072CC020000 0 072DD010000 68470 072DD020000 3705 072EE000000 0 073 A010000 0.7307 073 A020000 0.5575 073 B000000 0.0000 073 C000000 0.0000 074 A000000 6154 074 B000000 0 074 C000000 0 074 D000000 455941 074 E000000 215269 074 F000000 2749621 074 G000000 158 074 H000000 0 074 I000000 5544 074 J000000 1057 074 K000000 0 074 L000000 28893 074 M000000 203 074 N000000 3462840 074 O000000 6561 074 P000000 1525 074 Q000000 0 074 R010000 0 PAGE 9 074 R020000 0 074 R030000 14468 074 R040000 6938 074 S000000 0 074 T000000 3433348 074 U010000 96665 074 U020000 6658 074 V010000 25.80 074 V020000 21.95 074 W000000 0.0000 074 X000000 296090 074 Y000000 1431895 075 A000000 0 075 B000000 3067297 076 000000 0.00 077 A000000 Y 077 B000000 Y 077 C000000 N 077 D000000 N 077 E000000 Y 077 F000000 N 077 G000000 N 077 H000000 N 077 I000000 N 077 J000000 N 077 K000000 N 077 L000000 N 077 M000000 N 077 N000000 N 077 O000000 N 077 P000000 N 077 Q010000 Y 077 Q020000 N 077 Q030000 N 078 000000 N 080 A000000 ICI Mutual Insurance Co. 080 C000000 130000 081 A000000 Y 081 B000000 115 082 A000000 N 082 B000000 0 083 A000000 N 083 B000000 0 084 A000000 N 084 B000000 0 085 A000000 Y 085 B000000 N 086 A010000 0 086 A020000 0 086 B010000 0 086 B020000 0 PAGE 10 086 C010000 0 086 C020000 0 086 D010000 0 086 D020000 0 086 E010000 0 086 E020000 0 086 F010000 0 086 F020000 0 SIGNATURE BRIAN W. WIXTED TITLE TREASURER EX-23 2 form_ex23-835.htm OPPENHEIMER EQUITY INCOME FUND, INC. form_ex23-835.htm

Report of Independent Registered Public Accounting Firm

The Board of Directors and Shareholders

Oppenheimer Equity Income Fund, Inc.:

In planning and performing our audit of the financial statements of Oppenheimer Equity Income Fund, Inc. (the Fund) as of and for the year ended October 31, 2012, in accordance with the standards of the Public Company Accounting Oversight Board (United States), we considered the Fund’s internal control over financial reporting, including controls over safeguarding securities, as a basis for designing our auditing procedures for the purpose of expressing our opinion on the financial statements and to comply with the requirements of Form N-SAR, but not for the purpose of expressing an opinion on the effectiveness of the Fund’s internal control over financial reporting. Accordingly, we express no such opinion.

Management of the Fund is responsible for establishing and maintaining effective internal control over financial reporting. In fulfilling this responsibility, estimates and judgments by management are required to assess the expected benefits and related costs of controls. A company’s internal control over financial reporting is a process designed to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles. A company’s internal control over financial reporting includes those policies and procedures that (1) pertain to the maintenance of records that, in reasonable detail, accurately and fairly reflect the transactions and dispositions of the assets of the company; (2) provide reasonable assurance that transactions are recorded as necessary to permit preparation of financial statements in accordance with generally accepted accounting principles, and that receipts and expenditures of the company are being made only in accordance with authorizations of management and directors of the company; and (3) provide reasonable assurance regarding prevention or timely detection of unauthorized acquisition, use, or disposition of the company’s assets that could have a material effect on the financial statements.

Because of its inherent limitations, internal control over financial reporting may not prevent or detect misstatements. Also, projections of any evaluation of effectiveness to future periods are subject to the risk that controls may become inadequate because of changes in conditions, or that the degree of compliance with the policies or procedures may deteriorate.

A deficiency in internal control over financial reporting exists when the design or operation of a control does not allow management or employees, in the normal course of performing their assigned functions, to prevent or detect misstatements on a timely basis. A material weakness is a deficiency, or a combination of deficiencies, in internal control over financial reporting, such that there is a reasonable possibility that a material misstatement of the Fund’s annual or interim financial statements will not be prevented or detected on a timely basis.

Our consideration of the Fund’s internal control over financial reporting was for the limited purpose described in the first paragraph and would not necessarily disclose all deficiencies in internal control that might be material weaknesses under standards established by the Public Company Accounting Oversight Board (United States). However, we noted no deficiencies in the Fund’s internal control over financial reporting and its operation, including controls over safeguarding securities, that we consider to be a material weakness as defined above as of October 31, 2012.

This report is intended solely for the information and use of management and the Board of Directors of Oppenheimer Equity Income Fund, Inc. and the Securities and Exchange Commission, and is not intended to be and should not be used by anyone other than these specified parties.

KPMG LLP

Denver, Colorado

December 17, 2012

EX-99.77E LEGAL 3 form_ex77e-835.htm OPPENHEIMER EQUITY INCOME FUND, INC. form_ex77e-835.htm

N-SAR EXHIBIT 77E

Pending Litigation. Since 2009, a number of class action lawsuits have been pending in federal courts against OppenheimerFunds, Inc., the Fund’s investment advisor (the “Manager”), OppenheimerFunds Distributor, Inc., the Fund’s principal underwriter and distributor (the “Distributor”), and certain funds (but not including the Fund) advised by the Manager and distributed by the Distributor (the “Defendant Funds”). Several of these lawsuits also name as defendants certain officers and current and former trustees of the respective Defendant Funds. The lawsuits raise claims under federal securities law and allege, among other things, that the disclosure documents of the respective Defendant Funds contained misrepresentations and omissions and that the respective Defendant Funds’ investment policies were not followed. The plaintiffs in these actions seek unspecified damages, equitable relief and awards of attorneys’ fees and litigation expenses. The Defendant Funds’ Boards of Trustees have also engaged counsel to represent the Funds and the present and former Independent Trustees named in those suits.

Other class action and individual lawsuits have been filed since 2008 in various state and federal courts against the Manager and certain of its affiliates by investors seeking to recover investments they allegedly lost as a result of the “Ponzi” scheme run by Bernard L. Madoff and his firm, Bernard L. Madoff Investment Securities, LLC (“BLMIS”). Plaintiffs in these suits allege that they suffered losses as a result of their investments in several funds managed by an affiliate of the Manager and assert a variety of claims, including breach of fiduciary duty, fraud, negligent misrepresentation, unjust enrichment, and violation of federal and state securities laws and regulations, among others. They seek unspecified damages, equitable relief and awards of attorneys’ fees and litigation expenses. Neither the Distributor, nor any of the Oppenheimer mutual funds, their independent trustees or directors are named as defendants in these lawsuits. None of the Oppenheimer mutual funds invested in any funds or accounts managed by Madoff or BLMIS. On February 28, 2011, a stipulation of partial settlement of three groups of consolidated putative class action lawsuits relating to these matters was filed in the U.S. District Court for the Southern District of New York. On August 19, 2011, the court entered an order and final judgment approving the settlement as fair, reasonable and adequate. In September 2011, certain parties filed notices of appeal from the court’s order approving the settlement. The settlement does not resolve other outstanding lawsuits against the Manager and its affiliates relating to BLMIS.

On April 16, 2010, a lawsuit was filed in New York state court against the Manager, an affiliate of the Manager and AAArdvark IV Funding Limited (“AAArdvark IV”), an entity advised by the Manager’s affiliate, in connection with investments made by the plaintiffs in AAArdvark IV. Plaintiffs allege breach of contract against the defendants and seek compensatory damages, costs and disbursements, including attorney fees. On July 15, 2011, a lawsuit was filed in New York state court against the Manager, an affiliate of the Manager and AAArdvark Funding Limited (“AAArdvark I”), an entity advised by the Manager’s affiliate, in connection with investments made by the plaintiffs in AAArdvark I. The complaint alleges breach of contract against the defendants and seeks compensatory damages, costs and disbursements, including attorney fees. On November 9, 2011, a lawsuit was filed in New York state court against the Manager, an affiliate of the Manager and AAArdvark XS Funding Limited (“AAArdvark XS”), an entity advised by the Manager’s affiliate, in connection with investments made by the plaintiffs in AAArdvark XS. The complaint alleges breach of contract against the defendants and seeks compensatory damages, costs and disbursements, including attorney fees.

The Manager believes the lawsuits and appeals described above are without legal merit and, with the exception of actions it has settled, is defending against them vigorously. While it is premature to render any opinion as to the outcome in these lawsuits, or whether any costs that the Defendant Funds may bear in defending the suits might not be reimbursed by insurance, the Manager believes that these suits should not impair the ability of the Manager or the Distributor to perform their respective duties to the Fund, and that the outcome of all of the suits together should not have any material effect on the operations of any of the Oppenheimer mutual funds.

EX-99.77Q1 OTHR EXHB 4 form_ex77q1-835.htm OPPENHEIMER EQUITY INCOME FUND, INC. form_ex77q1-835.htm

Oppenheimer Equity Income Fund, Inc.

NSAR EXHIBIT 77Q1

AMENDED AND RESTATED

INVESTMENT ADVISORY AGREEMENT

AMENDED AND RESTATED ADVISORY AGREEMENT, made the 1st day of October, 2012, by and between Oppenheimer Equity Income Fund, Inc. (formerly named Oppenheimer Quest Capital Value Fund, Inc.), a Maryland corporation (hereinafter referred to as the "Company"), and OppenheimerFunds, Inc. (hereinafter referred to as "OFI").

WHEREAS, the Company is an open-end, diversified management investment company registered as such with the Securities and Exchange Commission (the "Commission") pursuant to the Investment Company Act of 1940 (the "Investment Company Act"), and OFI is an investment adviser registered as such with the Commission under the Investment Advisers Act of 1940;

WHEREAS, the Company and OFI entered into an Investment Advisory Agreement dated February 28, 1997, as amended and restated on January 1, 2005 and August 1, 2007; and

WHEREAS, the Company and OFI agreed, per a resolution adopted by the Fund’s Board of Directors at its September 13, 2012 meeting, to adopt the fee schedule shown in Schedule A of this Agreement;

NOW, THEREFORE, in consideration of the mutual promises and covenants hereinafter set forth, it is agreed by and between the parties, as follows:

1. General Provisions:

The Company hereby employs OFI and OFI hereby undertakes to act as the investment adviser of the Company, and to perform for the Company such other duties and functions for the period and on such terms as set forth in this Agreement. OFI shall, in all matters, give to the Company and its Board of Directors (the "Directors") the benefit of its best judgment, effort, advice and recommendations and shall at all times conform to, and use its best efforts to enable the Company to conform to (i) the provisions of the Investment Company Act and any rules or regulations thereunder; (ii) any other applicable provisions of state or Federal law; (iii) the provisions of the Articles of Incorporation and By-Laws of the Company as amended from time to time; (iv) policies and determinations of the Directors; (v) the fundamental policies and investment restrictions as reflected in the registration statement of the Company under the Investment Company Act or as such policies may, from time to time, be amended and (vi) the Prospectus and Statement of Additional Information in effect from time to time. The appropriate officers and employees of OFI shall be available upon reasonable notice for consultation with any of the Directors and officers of the Company with respect to any matters dealing with the business and affairs of the Company including the valuation of portfolio securities of the Company which are either not registered for public sale or not traded on any securities market.

2. Investment Management:

(a) OFI shall, subject to the direction and control by the Directors, (i) regularly provide investment advice and recommendations to the Company with respect to the investments, investment policies and the purchase and sale of securities; (ii) supervise continuously the investment program of the Company and the composition of its portfolio and determine what securities shall be purchased or sold by the Company; and (iii) arrange, subject to the provisions of paragraph 7 hereof, for the purchase of securities and other investments by the Company and the sale of securities and other investments held in the Company's portfolio.

(b) Provided that the Company shall not be required to pay any compensation for services under this Agreement other than as provided by the terms of the Agreement and subject to the provisions of paragraph 7 hereof, OFI may obtain investment information, research or assistance from any other person, firm or corporation to supplement, update or otherwise improve its investment management services.

(c) Provided that nothing herein shall be deemed to protect OFI from willful misfeasance, bad faith or gross negligence in the performance of its duties, or reckless disregard of its obligations and duties under this Agreement, OFI shall not be liable for any loss sustained by reason of good faith errors or omissions in connection with any matters to which this Agreement relates.

(d) Nothing in this Agreement shall prevent OFI or any entity controlling, controlled by or under common control with OFI or any officer thereof from acting as investment adviser for any other person, firm or corporation or in any way limit or restrict OFI or any of its directors, officers, stockholders or employees from buying, selling or trading any securities for its or their own account or for the account of others for whom it or they may be acting, provided that such activities will not adversely affect or otherwise impair the performance by OFI of its duties and obligations under this Agreement.

3. Other Duties of OFI:

OFI shall, at its own expense, provide and supervise the activities of all administrative and clerical personnel as shall be required to provide effective corporate administration for the Company, including the compilation and maintenance of such records with respect to its operations as may reasonably be required; the preparation and filing of such reports with respect thereto as shall be required by the Commission; composition of periodic reports with respect to operations of the Company for its shareholders; composition of proxy materials for meetings of the Company's shareholders; and the composition of such registration statements as may be required by Federal and state securities laws for continuous public sale of Shares of the Company. OFI shall, at its own cost and expense, also provide the Company with adequate office space, facilities and equipment. OFI shall, at its own expense, provide such officers for the Company as the Board of Directors may request.

4. Allocation of Expenses:

All other costs and expenses of the Company not expressly assumed by OFI under this Agreement, or to be paid by OppenheimerFunds Distributor, Inc., the distributor of the shares of the Company, shall be paid by the Company, including, but not limited to: (i) interest, taxes and governmental fees; (ii) brokerage commissions and other expenses incurred in acquiring or disposing of the portfolio securities and other investments; (iii) insurance premiums for fidelity and other coverage requisite to its operations; (iv) compensation and expenses of its Directors other than those affiliated with OFI; (v) legal and audit expenses; (vi) custodian and transfer agent fees and expenses; (vii) expenses incident to the redemption of its Shares; (viii) expenses incident to the issuance of its Shares against payment therefor by or on behalf of the subscribers thereto; (ix) fees and expenses, other than as hereinabove provided, incident to the registration under Federal and state securities laws of Shares of the Company for public sale; (x) expenses of printing and mailing reports, notices and proxy materials to shareholders of the Company; (xi) except as noted above, all other expenses incidental to holding meetings of the Company's shareholders; and (xii) such extraordinary non-recurring expenses as may arise, including litigation, affecting the Company and any legal obligation which the Company may have to indemnify its officers and Directors with respect thereto. Any officers or employees of OFI or any entity controlling, controlled by, or under common control with OFI who also serve as officers, Directors or employees of the Company shall not receive any compensation from the Company for their services.

5. Compensation of OFI:

The Company agrees to pay OFI and OFI agrees to accept as full compensation for the performance of all functions and duties on its part to be performed pursuant to the provisions hereof, a fee computed on the total net asset value of the Company as of the close of each business day and payable monthly at the annual rate set forth on Schedule A hereto.

6. Use of Name "Oppenheimer":

OFI hereby grants to the Company a royalty-free, non-exclusive license to use the name "Oppenheimer" in the name of the Company for the duration of this Agreement and any extensions or renewals thereof. To the extent necessary to protect OFI's rights to the name "Oppenheimer" under applicable law, such license shall allow OFI to inspect, subject to control by the Company's Board, control the nature and quality of services offered by the Company under such name and may, upon termination of this Agreement, be terminated by OFI, in which event the Company shall promptly take whatever action may be necessary to change its name and discontinue any further use of the name "Oppenheimer" in the name of the Company or otherwise. The name "Oppenheimer" may be used or licensed by OFI in connection with any of its activities, or licensed by OFI to any other party.

7. Portfolio Transactions and Brokerage:

(a) OFI is authorized, in arranging the purchase and sale of the portfolio securities of the Company, to employ or deal with such members of securities or commodities exchanges, brokers or dealers (hereinafter "broker-dealers"), including "affiliated" broker-dealers (as that term is defined in the Investment Company Act), as may, in its best judgment, implement the policy of the Fund to obtain, at reasonable expense, the "best execution" (prompt and reliable execution at the most favorable security price obtainable) of the portfolio transactions of the Company as well as to obtain, consistent with the provisions of subparagraph (c) of this paragraph 7, the benefit of such investment information or research as will be of significant assistance to the performance by OFI of its investment management functions.

(b) OFI shall select broker-dealers to effect the portfolio transactions of the Company on the basis of its estimate of their ability to obtain best execution of particular and related portfolio transactions. The abilities of a broker-dealer to obtain best execution of particular portfolio transaction(s) will be judged by OFI on the basis of all relevant factors and considerations including, insofar as feasible, the execution capabilities required by the transaction or transactions; the ability and willingness of the broker-dealer to facilitate the portfolio transactions of the Company by participating therein for its own account; the importance to the Company of speed, efficiency or confidentiality; the broker-dealer's apparent familiarity with sources from or to whom particular securities might be purchased or sold; as well as any other matters relevant to the selection of a broker-dealer for particular and related transactions of the Company.

(c) OFI shall have discretion, in the interest of the Company, to allocate brokerage on the portfolio transactions of the Company to broker-dealers, other than an affiliated broker-dealer, qualified to obtain best execution of such transactions who provide brokerage and/or research services (as such services are defined in Section 28(e)(3) of the Securities Exchange Act of 1934) for the Company and/or other accounts for which OFI or its affiliates exercise "investment discretion" (as that term is defined in Section 3(a)(35) of the Securities Exchange Act of 1934) and to cause the Company to pay such broker-dealers a commission for effecting a portfolio transaction for the Company that is in excess of the amount of commission another broker-dealer adequately qualified to effect such transaction would have charged for effecting that transaction, if OFI determines, in good faith, that such commission is reasonable in relation to the value of the brokerage and/or research services provided by such broker-dealer viewed in terms of either that particular transaction or the overall responsibilities of OFI or its affiliates with respect to accounts as to which they exercise investment discretion. In reaching such determination, OFI will not be required to place or attempt to place a specific dollar value on the brokerage and/or research services provided or being provided by such broker-dealer. In demonstrating that such determinations were made in good faith, OFI shall be prepared to show that all commissions were allocated for purposes contemplated by this Agreement and that the total commissions paid by the Company over a representative period selected by the Company's Directors were reasonable in relation to the benefits to the Company.

(d) OFI shall have no duty or obligation to seek advance competitive bidding for the most favorable commission rate applicable to any particular portfolio transactions or to select any broker-dealer on the basis of its purported or "posted" commission rate but will, to the best of its ability, endeavor to be aware of the current level of the charges of eligible broker-dealers and to minimize the expense incurred by the Company for effecting its portfolio transactions to the extent consistent with the interests and policies of the Company as established by the determinations of the Board of Directors of the Company and the provisions of this paragraph 7.

(e) The Company recognizes that an affiliated broker-dealer: (i) may act as one of the Company's regular brokers for the Company so long as it is lawful for it so to act; (ii) may be a major recipient of brokerage commissions paid by the Company; and (iii) may effect portfolio transactions for the Company thereof only if the commissions, fees or other remuneration received or to be received by it are determined in accordance with procedures contemplated by any rule, regulation or order adopted under the Investment Company Act for determining the permissible level of such commissions.

8. Duration:

This Agreement will take effect on the date first set forth above. Unless earlier terminated pursuant to paragraph 9 hereof, this Agreement shall remain in effect from year to year, so long as such continuance shall be approved at least annually by the Company's Board of Directors, including the vote of the majority of the Directors of the Company who are not parties to this Agreement or "interested persons" (as defined in the Investment Company Act) of any such party, cast in person at a meeting called for the purpose of voting on such approval, or by the holders of a "majority" (as defined in the Investment Company Act) of the outstanding voting securities of the Company, and by such a vote of the Company's Board of Directors.

9. Termination:

This Agreement may be terminated (i) by OFI at any time without penalty upon sixty days' written notice to the Company (which notice may be waived by the Company); or (ii) by the Company at any time without penalty upon sixty days' written notice to OFI (which notice may be waived by OFI) provided that such termination by the Company shall be directed or approved by the vote of a majority of all of the Directors of the Company then in office or by the vote of the holders of a "majority" of the outstanding voting securities of the Company (as defined in the Investment Company Act).

10. Assignment or Amendment:

This Agreement may not be amended, or the rights of OFI hereunder sold, transferred, pledged or otherwise in any manner encumbered without the affirmative vote or written consent of the holders of the "majority" of the outstanding voting securities of the Company. This Agreement shall automatically and immediately terminate in the event of its "assignment," as defined in the Investment Company Act.

11. Definitions:

The terms and provisions of the Agreement shall be interpreted and defined in a manner consistent with the provisions and definitions contained in the Investment Company Act.

Oppenheimer Equity Income Fund, Inc.

By: /s/ Arthur S. Gabinet

Arthur S. Gabinet

Secretary

OppenheimerFunds, Inc.

By: /s/ Lisa I. Bloomberg

Lisa I. Bloomberg

Senior Vice President and

Deputy General Counsel

Schedule A

Investment Advisory Agreement

between

Oppenheimer Equity Income Fund, Inc.

and

OppenheimerFunds, Inc.

Annual Fee as a Percentage of Average Annual Net Assets

0.70% of the first $400 million of average annual net assets;

0.68% of the next $400 million of average annual net assets;

0.65% of the next $400 million of average annual net assets;

0.60% of the next $400 million of average annual net assets;

0.55% of the next $400 million of average annual net assets;

0.50% of the next $3 billion of average annual net assets; and

0.45% of average annual net assets in excess of $5 billion.

EX-99 5 form_ex99a-835.htm OPPENHEIMER EQUITY INCOME FUND, INC. form_ex99a-835.htm

Net investment income (loss) and net realized gain (loss) may differ for financial statement

and tax purposes. The character of dividends and distributions made during the fiscal year

from net investment income or net realized gains may differ from their ultimate

characterization for federal income tax purposes. Also, due to timing of dividends and

distributions, the fiscal year in which amounts are distributed may differ from the fiscal

year in which the income or net realized gain was recorded by the Fund.

Accordingly, the following amounts have been reclassified for October 31, 2012. Net assets

of the Fund were unaffected by the reclassifications.

Reduction Increase

to Accumulated to Accumulated Net

Increase to Net Investment Realized Loss

Paid-in Capital Loss on Investments5

-----------------------------------------------------------------------------------------------------------

$ 4,903,493 $ 8,268,540 $ 13,172,033

5. $4,741,360, including $3,549,414 of long-term capital gain, was distributed in connection with Fund share redemptions.